## CCEP: Coca-Cola Europacific Partners  - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 1.42 indicates fundamental undervaluation. Quality metrics strong (ROE 18%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($85.99)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Transactions in Own Shares**
- Source: Actusnews | 20251209T080917 | Bullish | Relevance: 99%
-  Coca-Cola Europacific Partners plc announced transactions in its own shares, purchasing a total of 36,515 ordinary shares on US Trading Venues and 25,000 ordinary shares on London Trading Venues on December 8, 2025. These repurchases are part of the company's share buyback programme, which aims to repurchase up to EUR 1 billion of ordinary shares, and the repurchased shares will be cancelled.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 16.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Invesco Ltd.: 3.5% (+31.6%)
- Blackrock Inc.: 3.4% (-1.3%)
- Vanguard Group Inc: 2.4% (+2.6%)
- Goldman Sachs Group : 1.5% (+6.9%)
- Boston Partners: 1.4% (+2.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.42 suggests fair value with growth premium. Forward P/E 20.0x stretched relative to 9% growth. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $40.6B |
| Beta | 0.38 |
| 52W Range | $73.40 - $100.67 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.42 |
| Forward P/E | 20.0 |
| Current P/E | 21.8 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -2.4% to -3.7% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.7pp (needs >4.0% for momentum thesis). Below SMA200 (0.99x), long-term trend not supportive. RSI neutral at 42.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.69% (CS: 17) | Weak |
| RSI_14 | 42.5 | Neutral |
| MACD Histogram | -0.25 | Bearish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 0.990x | Below |
| vs SMA200 | 0.989x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $89.13
- **Stop Loss:** $85.99 (3.5% risk)
- **Target:** $95.41 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 439
- **Position Value:** $39,128.07
- **Portfolio %:** 39.13%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-17 (Est: $0.00)

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*